← FDA Drug Approvals (Drugs@FDA)
SILDENAFIL CITRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2021-05-11
Drug application
- FDA Application #
ANDA213014- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SILDENAFIL CITRATE
- Generic name
- SILDENAFIL POWDER,
- Active ingredients
- SILDENAFIL CITRATE
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HETERO LABS LTD V
- Manufacturer
- Camber Pharmaceuticals, Inc.
- First approval
- 2021-05-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown